Last reviewed · How we verify

NCT04146532

Aspirin Effects on Emotional Reactions

Completed EARLY_PHASE1 Last updated 3 June 2024
What this trial tests

EARLY_PHASE1 trial testing Aspirin 500 MG in Healthy Adults in 268 participants. Completed in 15 April 2022.

Timeline
8 October 2019
Primary endpoint
15 April 2022
15 April 2022

Quick facts

Lead sponsorOhio State University
PhaseEARLY_PHASE1
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposebasic science
Enrollment268
Start date8 October 2019
Primary completion15 April 2022
Estimated completion15 April 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Ohio State University

Who can join

18 and older, male only, with Healthy Adults. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to determine whether the drug aspirin has effects on emotional reactivity, emotional memory, and risk-taking behaviors.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Healthy Adults

Currently open trials in the same condition.

Other Ohio State University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04146532.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing